Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

BACKGROUND: Relapse of major depressive disorder (MDD) is a common clinical problem. This study was designed to determine whether residual sleep disturbance (insomnia and hypersomnia) predict risk of relapse during the continuation and maintenance treatment of MDD. METHODS: A total of 570 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huaiyu, Sinicropi-Yao, Lara, Chuzi, Sarah, Youn, Soo Jeong, Clain, Alisabet, Baer, Lee, Chen, Ying, McGrath, Patrick J, Fava, Maurizio, Papakostas, George I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Primary research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837657/
https://www.ncbi.nlm.nih.gov/pubmed/20187924
http://dx.doi.org/10.1186/1744-859X-9-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837657/
https://www.ncbi.nlm.nih.gov/pubmed/20187924
http://dx.doi.org/10.1186/1744-859X-9-10

Ejemplares similares